rutecarpine has been researched along with Inflammation in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Chen, NY; Gao, DF; Li, XW; Mo, DL; Pan, CX; Qin, LQ; Su, GF; Su, JC; Sun, JY; Wang, W | 1 |
| Chen, Y; Han, M; Hu, L | 1 |
| Han, X; Jiang, X; Li, N; Li, Y; Liu, C; Luo, J; Si, S; Wang, X; Xu, Y; Zuo, X | 1 |
| Bhattacharjee, A; Biswas, K; Chatterjee, A; Gurung, AB; Joshi, SR; Pamay, P; Tripathy, D | 1 |
| Gu, JA; Huang, SH; Huang, ST; Lee, CM; Lin, CM; Lin, FY; Rau, TG; Yang, CH; Yang, WC | 1 |
| Bian, K; Nie, XQ; Shi, HX; Yang, JW; Yuan, Y; Zhang, JY; Zhang, YJ | 1 |
| Aggarwal, BB; Kobayashi, Y; Takada, Y | 1 |
| Chang, HW; Kang, SS; Kim, HP; Kudo, I; Moon, TC; Murakami, M; Son, KH | 1 |
9 other study(ies) available for rutecarpine and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Design and synthesis of pseudo-rutaecarpines as potent anti-inflammatory agents via regulating MAPK/NF-κB pathways to relieve inflammation-induced acute liver injury in mice.
Topics: Animals; Anti-Inflammatory Agents; Inflammation; Lipopolysaccharides; Liver; Mice; NF-kappa B; RAW 264.7 Cells | 2023 |
Rutaecarpine may improve neuronal injury, inhibits apoptosis, inflammation and oxidative stress by regulating the expression of ERK1/2 and Nrf2/HO-1 pathway in rats with cerebral ischemia-reperfusion injury.
Topics: Animals; Apoptosis; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Heme Oxygenase-1; Indole Alkaloids; Inflammation; Male; MAP Kinase Signaling System; Neurons; NF-E2-Related Factor 2; Oxidative Stress; Quinazolines; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2019 |
Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport.
Topics: Animals; Atherosclerosis; Biological Transport, Active; Cholesterol; Indole Alkaloids; Inflammasomes; Inflammation; Macrophages; Mice; Mice, Knockout, ApoE; NLR Family, Pyrin Domain-Containing 3 Protein; Quinazolines | 2020 |
Bioprospection of anti-inflammatory phytochemicals suggests rutaecarpine and quinine as promising 15-lipoxygenase inhibitors.
Topics: Arachidonate 15-Lipoxygenase; Cyclooxygenase 2; HEK293 Cells; Humans; Indole Alkaloids; Inflammation; Lipoxygenase Inhibitors; Molecular Docking Simulation; Molecular Dynamics Simulation; Neoplasms; Phytochemicals; Quinazolines; Quinine; Structure-Activity Relationship | 2019 |
Low-cytotoxic synthetic bromorutaecarpine exhibits anti-inflammation and activation of transient receptor potential vanilloid type 1 activities.
Topics: Anti-Inflammatory Agents; Cardiovascular Diseases; Drugs, Chinese Herbal; Evodia; Gene Expression Regulation; Humans; Indole Alkaloids; Inflammation; Macrophages; Nitric Oxide Synthase Type II; Quinazolines; TRPV Cation Channels | 2013 |
[Effects of rutaecarpine on inflammatory cytokines in insulin resistant primary skeletal muscle cells].
Topics: Animals; Cell Proliferation; Cytokines; Female; Glucose; Indole Alkaloids; Inflammation; Insulin Resistance; Male; Muscle, Skeletal; Quinazolines; Rats | 2014 |
Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion.
Topics: Active Transport, Cell Nucleus; Alkaloids; Annexin A5; Apoptosis; Carcinogens; Cell Line, Tumor; Cell Proliferation; Collagen; Cytokines; Dose-Response Relationship, Drug; Down-Regulation; Drug Combinations; Enzyme Activation; Evodia; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; I-kappa B Kinase; Immunohistochemistry; Immunoprecipitation; In Situ Nick-End Labeling; Indole Alkaloids; Inflammation; Laminin; MAP Kinase Signaling System; Microscopy, Fluorescence; Models, Chemical; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plant Extracts; Protein Serine-Threonine Kinases; Proteoglycans; Quinazolines; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation | 2005 |
A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Electrophoresis, Polyacrylamide Gel; Fruit; Humans; Immunoblotting; Indole Alkaloids; Inflammation; Isoenzymes; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Plant Extracts; Plants, Medicinal; Prostaglandin-Endoperoxide Synthases; Quinazolines; Rats; Rats, Sprague-Dawley; Transfection | 1999 |